Highlights
- ResMed (ASX: RMD) shares declined 3.05% from the previous closing price.
- The healthcare stock traded within a narrow intraday range amid active market participation.
- ResMed's market capitalisation stood at approximately AUD 44.98 billion during the session.
ResMed Inc. (ASX:RMD) shares traded lower during the latest trading session, declining 3.05% to AUD 30.240 from the previous close of AUD 31.190. The healthcare equipment and services company recorded steady trading activity as investors monitored movements across the healthcare sector.
Listed on the Australian Securities Exchange (ASX), ResMed had a market capitalisation of approximately AUD 44.98 billion based on the latest available trading data.
RMD Shares Trade Lower
ResMed shares traded between an intraday low of AUD 29.680 and a high of AUD 30.260 during the latest session. At the latest quoted prices, the stock was bid at AUD 30.230 and offered at AUD 30.250.
The decline of AUD 0.949 represented a 3.05% decrease from the previous closing price. Despite the day's decline, the stock remained above its 52-week low of AUD 25.500 while trading below its 52-week high of AUD 45.250.
Trading Volume Near Average
The stock recorded trading volume of approximately 1.50 million shares during the session. This compared with an average daily trading volume of around 1.59 million shares, indicating trading activity was broadly in line with normal levels.
ResMed has approximately 1.44 billion CDIs on issue on a 10:1 foreign exempt basis, contributing to its market capitalisation of approximately AUD 44.98 billion.
Trading volume, together with price movements, is often monitored by market participants to assess activity levels during a trading session.
Company Overview
ResMed Inc. operates in the Health Care Equipment & Services industry group and has been listed on the ASX since 25 November 1999 under the ticker RMD.
The company's ASX-listed securities are structured as CDI 10:1 Foreign Exempt NYSE and carry the International Securities Identification Number (ISIN) AU000000RMD6.
Companies operating in the healthcare equipment sector may experience share price movements influenced by product demand, regulatory developments, earnings announcements, innovation, healthcare spending trends, and broader market conditions.
Market Snapshot
ResMed shares declined during the latest trading session while remaining within their 52-week trading range of AUD 25.500 to AUD 45.250. Trading activity remained close to the stock's average daily volume, reflecting continued investor participation.
Market participants continue monitoring price movements, trading volumes, and sector developments as the stock trades on the ASX.
Key Risks
- Regulatory changes may affect product approvals and commercial operations.
- Healthcare reimbursement policies can influence product demand.
- Currency fluctuations may impact reported financial performance.
- Market volatility can affect short-term share price movements.
Summary
ResMed (ASX:RMD) shares declined 3.05% to AUD 30.240 during the latest trading session after closing at AUD 31.190 previously. The stock traded between AUD 29.680 and AUD 30.260, with trading volume of approximately 1.50 million shares, close to its average daily turnover. The company currently has a market capitalisation of approximately AUD 44.98 billion.
FAQs
Q: What was ResMed's latest share price?
A: ResMed shares traded at AUD 30.240, down 3.05% from the previous closing price of AUD 31.190.
Q: What is ResMed's market capitalisation?
A: ResMed had a market capitalisation of approximately AUD 44.98 billion during the latest trading session.
Q: What is ResMed's 52-week trading range?
A: ResMed shares have traded between AUD 25.500 and AUD 45.250 over the past 52 weeks.